FACULTY


MELANOMA BRIDGE
December 3rd - December 5th, 2020
VIRTUAL MEETING


FACULTY


Sanjiv S. Agarwala
Professor & Chief, Haematology & Oncology, St Luke’s University Hospital and Temple University, Bethlehem, PA, US

Paolo A. Ascierto
Director, Medical Oncology, Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, National Cancer Institute Fondazione "G. Pascale", Naples, Italy

Michael B. Atkins
Deputy Director, Georgetown Lombardi Comprehensive Cancer Center, Scholl Professor and Vice Chair, Department of Medical Oncology, Georgetown University Medical Center, Washington, DC, US

Christian Blank
Medical Oncology and Research Group Leader Tumor Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands

Gerardo Botti
Scientific Director National Cancer Institute “Fondazione G. Pascale” Naples, Italy

Corrado Caracò
Director of Melanoma and Skin Tumor Surgery, National Cancer Institute “Fondazione G. Pascale”, Naples, Italy

Richard D. Carvajal
Director of Experimental Therapeutics and Director of the Melanoma Service, Columbia University Medical Center, New York, NY, US

Reinhard Dummer
Professor of Dermatology, University of Zurich Hospital, Department of Dermatology, Zurich, Switzerland

Alexander Eggermont
Professor of Oncological Surgery and General Director, Institut Gustave Roussy Villejuif, Paris-Sud, France

Marc Ernstoff
Professor, Department of Medicine, Katherine Anne Gioia Chair, Senior VP for Clinical Investigation, Roswell, Park Comprehensive Cancer Center and Professor of Medicine. Chief, Hematology & Oncology Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, State University, Buffalo, NY, US

Soldano Ferrone
Department of Surgery Massachusetts General Hospital, Harvard Medical School, Boston, MA, US

Bernard A. Fox
Chief of Laboratory of Molecular and Tumor Immunology, Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute at Providence Cancer Center, Portland, OR, US

Thomas Gajewski
Oncology and Immunology Professor, Department of Pathology and Department of Medicine (Section of Haematology/Oncology) - University of Chicago (Microbiome Center), Chicago, IL, US

Jerome Galon
Research Director, National Institute of Health and Medical Research (INSERM), Paris, France

Claus Garbe
University Professor of Dermatology, Division of Dermatologic Oncology Department of Dermatology, Eberhard- Karls University Tuebingen, Germany

Jeffrey E. Gershenwald
Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas, MD Anderson Cancer Center, Houston, TX, US

Jean-Jacques Grob
Professor, Head of Dermatology Department, Hopital de la Timone, Aix-Marseille, Marseille, France

Pawel Kalinski
Vice Chair for Translational Research, Department of Medicine, Director of Cancer Vaccine and Dendritic Cell Therapies, Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Developmental Therapeutics, Buffalo, NY, US

Michelle Krogsaard
Associate Professor of Pathology, New York University Langone, Medical School, New York, NY, US

Omid Hamid
Director Clinical Research and Immunotherapy at The Angeles Clinic and Research Institute, Los Angeles, CA, US

Patrick Hwu
Department of Melanoma Medical Oncology, Division of Cancer Medicine, Anderson Cancer Center, Houston, TX, US

Roger Lo
Melanoma Clinic in Dermatology Member, Jonsson Comprehensive Cancer Center David Geffen School of Medicine at UCLA, Los Angeles, CA, US

Georgina Long
Conjoint Medical Director Melanoma Institute Australia, Professor of Melanoma Medical Oncology and Translational Research Melanoma Institute Australia, The University of Sydney and Royal North Shore Hospital, Sydney, Australia

Jason Luke
Assistant Professor of Medicine University of Chicago, Chicago, IL, US

Giuseppe Masucci
Professor, Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden

Olivier Michielin
Personalised Analytical Oncology Division Director, Oncology Department UNIL—CHUV, Lausanne, Suisse

Paul Nathan
Consultant Medical Oncologist, Mount Vernon Cancer Centre, Northwood, Middlesex, UK

Bart Neyns
Head of division, Medical Oncology, Universitair Ziekenhuis, Brussel, Belgium

Iman Osman
Rudolf L. Baer MD Professor of Dermatology, Professor, Departments of Medicine (Oncology) and Urology, Director, Interdisciplinary Melanoma Program, Associate Dean for Translational Research Support, New York University Langone, Medical School, New York City, New York, US

Giuseppe Palmieri
President Italian Melanoma Intergroup (IMI), Head of Unit of Cancer Genetics, Institute of Biomolecular Chemistry (ICB), National Research Council (CNR), Sassari, Italy

Michael Postow
Memorial Sloan Kettering Cancer Center, New York, NY, USA

Igor Puzanov
Director, Early Phase Clinical Trials Program, Chief of Melanoma, Co-Leader, CCSG Experimental Therapeutics Program, Professor of Oncology, Department of Medicine, Roswell Park Comprehensive Cancer Center, Developmental Therapeutics, Buffalo, NY, US

Sergio Quezada
Professor of Cancer Immunology and Immunotherapy, Group Leader of Cancer Immunology Unit, Research Department of Hematology, Cancer Institute, University College London, London, UK

Vernon Sondak
Chair, Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, US

Jeffrey Sosman
Professor, Medicine, Hematology Oncology Division, Feinberg School of Medicine, Northwestern University, Chicago, IL, US

Hussein Tawbi
Associate Professor, Director of Melanoma Clinical Research & Early Drug Development, Melanoma Medical Oncology, Investigational Cancer Therapeutics, UT MD Anderson Cancer Center, Houston, TX, US

Michele Teng
Associate Professor, Head of the Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia

Alessandro Testori
EORTC Melanoma Group Senior Consultant, Fondazione IRCCS San Matteo, Pavia, Italy

Magdalena Thurin
Program Director, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, MD, US

Giorgio Trinchieri
NIH Distinguished Investigator, Chief, Laboratory of Integrative Cancer Immunology (LICI) Center for Cancer Research, NCI, NIH, Bethesda, MD, US

Jeffrey S. Weber
Deputy Director, Professor of Oncology, Department of Medicine, Perlmutter Cancer Center, New York University Langone, Medical School, New York, NY, US




For information please contact info@melanomabridge.org